Medications used to induce labor

Not Applicable

• Conditions: Health Condition 1: O80- Encounter for full-term uncomplicated delivery

• Registration Number: CTRI/2023/10/058260
• Lead Sponsor: Dr Asmita Yadav

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Singleton, live gestation

• Primi and Multigravida

• Gestational age between 37 weeks 0 days - 42 weeks 0 days

• Fetus in cephalic presentation

• Patients admitted for labor induction

• Patients who are not in labor with intact membranes

• Patients with no contraindication for vaginal delivery

Exclusion Criteria

Significant cardiac, renal, or hepatic maternal comorbidities, severe gestational

hypertension or preeclampsia with severe features

? Pregnancies complicated by major fetal anomalies

? Pregnancies complicated by fetal growth restriction (Estimated fetal weight <10%)

? Fetuses with an estimated fetal weight >4500 gm by recent ultrasound or Leopold's

exam on admission

? Any indication for scheduled cesarean delivery

? Hypersensitivity to prostaglandins

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
vaginal & Caesarean delivery rates with each sequential cycleTimepoint: Day 1 Day 2 Day 3

Secondary Outcome Measures

Name	Time	Method
To evaluate maternal (Intrapartum <br/ ><br>chorionamnionitis, Post partum hemorrhage rates, ICU admissions) <br/ ><br>and perinatal outcomes (Birth weight, APGAR scores, Meconium <br/ ><br>stained amniotic fluid, NICU admissions) with sequential cycles of <br/ ><br>above mentioned agentsTimepoint: Day 1 <br/ ><br>Day 2 <br/ ><br>Day 3